Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 645

The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.

Current understanding of the molecular and cellular pathology of diabetic retinopathy

Open access
Antonetti, David A., Silva, Paolo S., Stitt, Alan W.·2021·Nature Reviews Endocrinology

Abstract

Diabetes mellitus has profound effects on multiple organ systems; however, the loss of vision caused by diabetic retinopathy might be one of the most impactful in a patient’s life. The retina is a highly metabolically active tissue that requires a complex interaction of cells, spanning light sensing photoreceptors to neurons that transfer the electrochemical signal to the brain with support by glia and vascular tissue. Neuronal function depends on a complex inter-dependency of retinal cells that includes the formation of a blood–retinal barrier. This dynamic system is negatively affected by diabetes mellitus, which alters normal cell–cell interactions and leads to profound vascular abnormalities, loss of the blood–retinal barrier and impaired neuronal function. Understanding the normal cell signalling interactions and how they are altered by diabetes mellitus has already led to novel therapies that have improved visual outcomes in many patients. Research highlighted in this Review has led to a new understanding of retinal pathophysiology during diabetes mellitus and has uncovered potential new therapeutic avenues to treat this debilitating disease. This Review focuses on the current understanding of the molecular and cellular pathology of diabetic retinopathy. The primary focus is on the cellular signalling between the neuronal and vascular retina that promotes formation of the inner blood–retinal barrier of the retinal vasculature as an important point of intervention. Diabetic retinopathy is a leading cause of blindness that disrupts the normal interaction of the retinal neural and vascular components leading to vascular permeability, neovascularization and loss of proper neural function. Current effective therapeutic approaches target vascular endothelial growth factor, while a host of new therapies targeting vascular endothelial and pericyte signalling and inflammatory cytokines are being tested for diabetic retinopathy. Stem cell therapy for vascular regeneration holds potential for restorative therapeutic approaches in diabetic retinopathy. Understanding the neuronal and glial changes that drive loss of vision is rapidly emerging, and targeted approaches to directly test the relationship between the neurovascular unit and alteration in diabetic retinopathy are needed. Diabetic retinopathy is a leading cause of blindness that disrupts the normal interaction of the retinal neural and vascular components leading to vascular permeability, neovascularization and loss of proper neural function. Current effective therapeutic approaches target vascular endothelial growth factor, while a host of new therapies targeting vascular endothelial and pericyte signalling and inflammatory cytokines are being tested for diabetic retinopathy. Stem cell therapy for vascular regeneration holds potential for restorative therapeutic approaches in diabetic retinopathy. Understanding the neuronal and glial changes that drive loss of vision is rapidly emerging, and targeted approaches to directly test the relationship between the neurovascular unit and alteration in diabetic retinopathy are needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41574-020-00451-4

Cites

152 of 152 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 152 references

Cited by

See all 645

Metadata

Authors
Antonetti, D. A., Silva, P. S., & Stitt, A. W.
Venue
Nature Reviews Endocrinology
Published
2021-01-19
Volume
17
Issue
4
Pages
195-206
ISSN
  • 1759-5029 (ISSN-L)
  • 1759-5037
OpenAlex
W3121608322
Cited by
645
References
152
FWCI
22.69
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Current understanding of the molecular and cellular pathology of diabetic retinopathy. https://app.cochat.ai/papers/10.1038/s41574-020-00451-4
The paper
Antonetti, D. A., Silva, P. S., & Stitt, A. W. (2021). Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nature Reviews Endocrinology. https://doi.org/10.1038/s41574-020-00451-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.